Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Schouten 2012 Netherlands | 406 consecutive primary care patients aged >50 years with a low clinical probability of DVT (Wells’ score ≤1). | Retrospective analysis of cohort studies | Proportion of patients with D-dimer levels below the conventional (500 µg/L) or age-adjusted (age×x10 µg/L) cut-offs who had DVT excluded by an ultrasound scan repeated at day 7. | All ages: Conventional: 42%, 95% CI 38.2% to 46% (n=272/647) Age-adjusted: 47.8%, 95% CI 43.9% to 51.7% (n=309/647). | Two studies are used to give these data—the second study adds additional patients to the original cohort of the first to validate the results. No data is given on the sensitivity of either test. |
False negative rate. | All ages: Conventional: 0.3%, 95% CI 0.04% to 1.1% (n=2/647) Age-adjusted: 0.5%, 95% CI 0.01% to 1.3% (n=3/647). | ||||
Douma 2012 Netherlands | Retrospective analysis of five cohorts of hospital outpatients with non-high clinical probability. Cohort 1:472 patients with Wells’ score ≤2. Cohort 2:419 patients with clinical probability estimated by treating doctor as being <80%. Cohort 3:297 patients with Wells’ score ≤2. Cohort 4:484 patients with Wells’ score ≤2. Cohort 5:212 hospital outpatients with low clinical probability of DVT (Wells’ score ≤1) | Retrospective analysis of 5 cohort studies | Proportion of patients with low clinical probability who had normal D-dimer levels according to the conventional (<500 µg/L) and age-adjusted (age×10 µg/L in patients aged >50 years) cut-offs. | Cohorts 1 to 4 (which classified patients as high or non-high clinical probability): Conventional 42%, 95% CI 40% to 45% (n=707/1672) Age-adjusted 51%, 95% CI 48% to 53% (n=850/1672)Cohort 5 (which classified patients as being likely or unlikely to have DVT): Conventional: 39.2%, n=83/212; Age-adjusted: 47%, n=100/212 | Authors have included patients with history of VTE and active malignancy. In cohort 5, 20% of patients had previous venous thromboembolism. 3-month follow-up was by meeting with clinician or telephone. Cohort 5: no CIs available for the patients below the D-dimer cut-off. Cohort 5: no confidence intervals available for the patients below the d dimer cut off. No data is given on the sensitivity of either test. |
Proportion of patients with low clinical probability who had normal D-dimer levels according to the conventional (<500 µg/L) and age-adjusted (age×10 µg/L in patients aged >50 years) cut-offs. Cohorts 1 to 4 (which classified patients as high or non-high clinical probability): Conventional 42%, 95% CI 40% to 45% (n=707/1672) Age-adjusted 51%, 95% CI 48% to 53% (n=850/1672)Cohort 5 (which classified patients as being likely or unlikely to have DVT): Conventional: 39.2%, n=83/212; Age-adjusted: 47%, n=100/212 Authors have included patients with history of VTE and active malignancy. In cohort 5, 20% of patients had previous venous thromboembolism. 3-month follow-up was by meeting with clinician or telephone. Cohort 5: no CIs available for the patients below the D-dimer cut-off. False negative rate | Cohorts 1 to 4: Conventional: 0%, 95% CI 0% to 3.5% (n=0/83) Age-adjusted: 0%, 95% CI 0% to 3.0% (n=0/100)Cohort 5: Conventional: 0.0%, 95% CI 0.0% to 3.5% (n=0/83) Age-adjusted: 0.0%, 95% CI 0.0% to 3.0% (n=0/100). | ||||
Tan 2011 Japan | Retrospective study of data of 606 patients with suspected DVT Four hundred patients (66%) were older than 50 years of age. | Retrospective cohort study. | Proportion of patients who had DVT excluded using conventional and age-adjusted (age×10 µg/L) cut-offs. | In patients aged over 50 years with low Wells’ score, conventional cut-off excluded 9.3% with age-adjusted cut-off, DVT excluded in 13.5%. | Journal conference abstract only. |
False negative rate. | The 3 month VTE failure rates were 0% (95% CI 0% to 7.8%) for conventional and 0% (95% CI 0% to 5.4%) for the age adjusted D-dimer cut-off point. |